The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...

The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier ...

Johnson & Johnson and Eli Lilly both sued the federal government this month over the future of their respective 340B drug rebate plans.

Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead ...

Analysts look at the likelihood of lawmakers making moves to rein in drug middlemen this session. Also, covid-era prescription flexibility is kept in place, pharmaceutical companies take on GLP-1 ...